ORIGINAL RESEARCH
Accepted on 29 Jul 2025
Retrospective analysis of the efficacy and safety of anlotinib plus sintilimab (anti-PD-1) as maintenance therapy in advanced pediatric solid tumors
doi 10.3389/fonc.2025.1518987
- 110 views
3,891
Total downloads
15k
Total views and downloads
ORIGINAL RESEARCH
Accepted on 29 Jul 2025
MINI REVIEW
Published on 01 May 2025
ORIGINAL RESEARCH
Published on 19 Mar 2025
ORIGINAL RESEARCH
Published on 07 Nov 2024
MINI REVIEW
Published on 08 Mar 2024
BRIEF RESEARCH REPORT
Published on 31 Jan 2024